The success of Sildenafil initially fueled a period of growth for pharma, however recent shifts present a uncertain outlook for those considering a stake. Lower-cost alternatives are reducing profits, and continued https://siobhanojqb493689.dm-blog.com/41489438/sildenafil-and-pharma-a-risky-bet